Full-year 2025 net product revenues of $689 millionSYFOVRE® (pegcetacoplan injection) full year 2025 net product revenue of $587 millionEMPAVELI® (pegcetacoplan) full year 2025 net product revenue of ...
Spinal cord injury often triggers a cascade of secondary damage that severely limits functional recovery, largely driven by ...
Explore how proteomics enhances infectious disease detection, pathogen identification, and host response profiling in ...
News-Medical.Net on MSN
Spatial intelligence platform supports health policy decisions aimed at ending HIV
INCLIVA Healthcare Research Institute-University Clinical Hospital of Valencia, the Universitat Politècnica de València - ...
OKX Unveils Toolkit For Autonomous Onchain Agents Arabian Post. <img decoding=async alt= border=0 width=320 ...
The UPV participates in HIVision Spain, a national HIV simulator designed to support health policy decisions to end the epidemic in Spain ...
Explore Marie Selby Botanical Gardens in Sarasota, Florida, where 6,000 orchids, bayfront views, canopy walks, and seasonal ...
Wallpaper* editors are a bit like plants: at the first hint of spring sunshine, we perk up, emerging from behind our screens to venture out into the world. What better moment than this season of ...
Chemical biomarkers are measurable molecular signatures (host immune markers, pathogen metabolites, volatile organic ...
In Texas State Parks, some restaurants turn a trail into a full-on feast, where the last step of the hike leads straight to something unforgettable.
Morning Overview on MSN
Scientists debut breakthrough molecule that sneaks DNA straight into living cells
A team led by Professor Shoichiro Asayama at Tokyo Metropolitan University has synthesized a charge-free molecule designed to sneak plasmid DNA into living cells via hydrogen bonding, dramatically ...
Morning Overview on MSN
World’s 1st targeted sepsis treatment hailed as potential lifesaving breakthrough
Grand Pharmaceutical Group Limited announced that its experimental drug STC3141 met the primary clinical endpoint in a Phase II trial conducted across sites in China, delivering a statistically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results